Some in the industry expected lobbying spending to level out ahead of the midterms and after numerous pandemic relief bills and the initial burst that a new administration provides.
Health
your username
8 hours ago Judge Max O. Cogburn Jr. of the Western District of North Carolina on Thursday denied the “rare remedy” of attorney’s fees in patent litigation to defendants who attempted to demonstrate that the suit brought against them was notable enough to yield such an award.
Composite Resources Inc. (CRI) originally filed suit against Combat Medical Systems LLC and Alphapointe, alleging that the defendants’ Tactical Mechanical Tourniquet product infringed on two of the plaintiff’s patents.
Despite the court ultimately finding that the defendants’ product did not infringe on the plaintiff’s patents, the defendants were not satisfied; they moved to recover attorney’s fees, alleging that CRI’s motivation behind its suit was to block the defendants from competing in the same market and lodging other claims in an attempt to prove that its circumstances were “extraordinary” enough to warrant an award of fees.